type 2 diabetes with dialysis patient
Conditions
Interventions
Teneligliptin 20mg/day 12 week
Sponsors
Tokatsu-Clinic Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients agreed to participate in this study with a written consent 2) Gender: agnostic 3) Age: 20 years old or older when obtaining consent 4) Inpatient and outpatient: hospitalization 5) Patients who continued diet and exercise therapy more than 12 weeks before day1. Exercise therapy is not essential if it is prohibited because of the complication.
Exclusion criteria
Exclusion criteria: 1)Type 1 diabetes,diabetes arising from the failure of pancreas,or secondary diabetes (eg. Cushing's syndrome and acromegaly) 2) Patient correspond to contraindications of teneligliptin 3) Excessive alcohol addicts: patient who take average net more than 60 g alcohol every single day (more than following: 3 bottles of sake, 1 with shochu, 3 bottles of beer, 3 glasses of whiskey or brandy(double),and 5 glasses of wine) 4) Pregnant, lactating, possible pregnant patient 1)Type 1 diabetes,diabetes arising from the failure of pancreas,or secondary diabetes (eg. Cushing's syndrome and acromegaly) 2) Patient correspond to contraindications of teneligliptin 3) Excessive alcohol addicts: patient who take average net more than 60 g alcohol every single day (more than following: 3 bottles of sake, 1 with shochu, 3 bottles of beer, 3 glasses of whiskey or brandy(double),and 5 glasses of wine) 4) Pregnant, lactating, possible pregnant patient 5) Patient judged as ineligible for this study by the researcher
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Change of HbA1c, GA, FPG after 12 weeks | — |
Countries
Japan
Contacts
Public ContactAkira Onozaki, Ichiro Tatsuno
Tokatsu-Clinic Hospital Internal medicine
Outcome results
None listed